Article thumbnail

Immunogenicity of two doses of pH1N1 vaccine.

By Darius Soonawala (193137), Guus F. Rimmelzwaan (50630), Luc B. S. Gelinck (356728), Leo G. Visser (193188) and Frank P. Kroon (356731)


<p>Monovalent MF59-adjuvanted pandemic influenza vaccine (A/California/7/2009) administered to a group of 57 HIV-infected patients (HIV) and 44 healthy controls (HC). The vaccine was administered at day 0 (baseline) and at day 21. Age adjusted geometric mean titers with 95% confidence intervals at baseline, day 7, day 21 and day 56 (<u>Panel A</u>). Reverse cumulative distribution curves on hemagglutination inhibition assay at baseline and at day 21 (<u>Panel B</u>).</p

Topics: Immunology, Infectious Diseases, Virology, doses, ph1n1
Year: 2013
DOI identifier: 10.1371/journal.pone.0016496.g001
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.